31 results on '"Shemshedini, Lirim"'
Search Results
2. MDM2 regulates the stability of AR, AR-V7, and TM4SF3 proteins in prostate cancer
3. The Transmembrane Protein TM4SF3 Interacts with AR and AR-V7 and is Recruited to AR Target Genes
4. Peptides disrupting TM4SF3 interaction with AR or AR-V7 block prostate cancer cell proliferation
5. Dual-Acting Peptides Target EZH2 and AR: A New Paradigm for Effective Treatment of Castration-Resistant Prostate Cancer
6. Dual-Acting Peptides Target EZH2 and AR: A New Paradigm for Effective Treatment of Castration-Resistant Prostate Cancer.
7. TM4SF3 and AR: A Nuclear Complex that Stabilizes Both Proteins
8. Resistance to Juvenile Hormone and an Insect Growth Regulator in Drosophila is Associated with an Altered Cytosolic Juvenile Hormone-Binding Protein
9. COP9 Subunits 4 and 5 Target Soluble Guanylyl Cyclase α1 and p53 in Prostate Cancer Cells
10. Soluble Guanylyl Cyclase α1 and p53 Cytoplasmic Sequestration and Down-Regulation in Prostate Cancer
11. Abstract 2072: TM4SF3 interaction with AR or AR-V7 is important for the survival of prostate cancer cells
12. Androgen up-regulation of Twist1 gene expression is mediated by ETV1
13. Identification of domains of c-Jun mediating androgen receptor transactivation
14. ETV1 Is a Novel Androgen Receptor-Regulated Gene that Mediates Prostate Cancer Cell Invasion
15. Ligand-Activated Retinoic Acid Receptor Inhibits AP-1 Transactivation by Disruptingc-Jun/c-Fos Dimerization
16. Peptide B targets soluble guanylyl cyclase α1 and kills prostate cancer cells
17. RNase L Suppresses Androgen Receptor Signaling, Cell Migration and Matrix Metalloproteinase Activity in Prostate Cancer Cells
18. Zinc Finger 280B Regulates sGCα1 and p53 in Prostate Cancer Cells
19. A Peptide against Soluble Guanylyl Cyclase α1: A New Approach to Treating Prostate Cancer
20. Abstract 215: Soluble guanylyl cyclase α1 and p53 cytoplasmic sequestration: A novel mechanism for p53 down-regulation in prostate cancer
21. Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells
22. c-Jun Has Multiple Enhancing Activities in the Novel Cross Talk between the Androgen Receptor and Ets Variant Gene 1 in Prostate Cancer
23. SUMO-3 Enhances Androgen Receptor Transcriptional Activity through a Sumoylation-independent Mechanism in Prostate Cancer Cells
24. Glycogen Synthase Kinase-3β Is Involved in the Phosphorylation and Suppression of Androgen Receptor Activity
25. c-Jun Potentiates the Functional Interaction between the Amino and Carboxyl Termini of the Androgen Receptor
26. p53 Represses Androgen-induced Transactivation of Prostate-specific Antigen by Disrupting hAR Amino- to Carboxyl-terminal Interaction
27. Ligand-Activated Retinoic Acid Receptor Inhibits AP-1 Transactivation by Disrupting c-Jun/c-Fos Dimerization
28. c-Jun Can Mediate Androgen Receptor-induced Transactivation
29. pLEF, a novel vector for expression of glutathione S-transferase fusion proteins in mammalian cells
30. SUMO-3 Enhances Androgen Receptor Transcriptional Activity through a Sumoylation-independent Mechanism in Prostate Cancer Cells.
31. Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activity.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.